Ombrabulin HCl (AV-E8062; AC-7700; AVE8062), an analogue of combretastatin A4 with improved water solubility, is a novel and potent tubulin inhibitor and vascular-disrupting agent with anticancer activity. It has better solubility and oral bioavailability, improved anti-cancer activity and decreased toxicity, and has been in 11 completed phase studies.

纯度：≥98%

CAS：253426-24-3